BEAM
Price
$16.76
Change
-$0.39 (-2.27%)
Updated
Jun 25, 04:59 PM (EDT)
Capitalization
1.69B
48 days until earnings call
TRDA
Price
$7.07
Change
-$0.01 (-0.14%)
Updated
Jun 25, 04:59 PM (EDT)
Capitalization
268.71M
42 days until earnings call
Interact to see
Advertisement

BEAM vs TRDA

Header iconBEAM vs TRDA Comparison
Open Charts BEAM vs TRDABanner chart's image
Beam Therapeutics
Price$16.76
Change-$0.39 (-2.27%)
Volume$37.47K
Capitalization1.69B
Entrada Therapeutics
Price$7.07
Change-$0.01 (-0.14%)
Volume$1.56K
Capitalization268.71M
BEAM vs TRDA Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. TRDA commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Buy and TRDA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2025
Stock price -- (BEAM: $17.15 vs. TRDA: $7.08)
Brand notoriety: BEAM and TRDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 71% vs. TRDA: 70%
Market capitalization -- BEAM: $1.69B vs. TRDA: $267.95M
BEAM [@Biotechnology] is valued at $1.69B. TRDA’s [@Biotechnology] market capitalization is $267.95M. The market cap for tickers in the [@Biotechnology] industry ranges from $312.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileTRDA’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • TRDA’s FA Score: 0 green, 5 red.
According to our system of comparison, both BEAM and TRDA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 3 TA indicator(s) are bullish while TRDA’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 3 bullish, 5 bearish.
  • TRDA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, TRDA is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а +2.88% price change this week, while TRDA (@Biotechnology) price change was -4.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.95%. For the same industry, the average monthly price growth was +32.23%, and the average quarterly price growth was +16.56%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 12, 2025.

TRDA is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+1.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.69B) has a higher market cap than TRDA($269M). BEAM YTD gains are higher at: -30.847 vs. TRDA (-59.051). TRDA has higher annual earnings (EBITDA): 7.89M vs. BEAM (-399.03M). BEAM has more cash in the bank: 1.22B vs. TRDA (383M). TRDA has less debt than BEAM: TRDA (57M) vs BEAM (158M). TRDA has higher revenues than BEAM: TRDA (172M) vs BEAM (63.6M).
BEAMTRDABEAM / TRDA
Capitalization1.69B269M626%
EBITDA-399.03M7.89M-5,056%
Gain YTD-30.847-59.05152%
P/E RatioN/A12.21-
Revenue63.6M172M37%
Total Cash1.22B383M319%
Total Debt158M57M277%
TECHNICAL ANALYSIS
Technical Analysis
BEAMTRDA
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 8 days ago
78%
Bullish Trend 20 days ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 9 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EMRGX7.810.18
+2.36%
Emerging Markets Equities Fund M
IBNAX24.19N/A
N/A
Macquarie Balanced Fund Class A
PRJCX39.04N/A
N/A
PGIM Jennison Global Opportunities C
JSPIX26.12N/A
N/A
Jackson Square Large-Cap Growth Instl
FAPMX12.78N/A
N/A
Fidelity Advisor Healthy Future I

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+2.63%
CRSP - BEAM
72%
Closely correlated
+2.70%
NTLA - BEAM
64%
Loosely correlated
+3.68%
RXRX - BEAM
63%
Loosely correlated
+8.07%
SYRE - BEAM
58%
Loosely correlated
+4.97%
AXON - BEAM
57%
Loosely correlated
+1.41%
More

TRDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been loosely correlated with CRNX. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if TRDA jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRDA
1D Price
Change %
TRDA100%
+0.57%
CRNX - TRDA
57%
Loosely correlated
+3.44%
ARCT - TRDA
53%
Loosely correlated
+7.19%
BEAM - TRDA
52%
Loosely correlated
+2.63%
VYGR - TRDA
52%
Loosely correlated
+2.04%
XERS - TRDA
51%
Loosely correlated
+0.43%
More